At-Home Treatment of Patients with Acute Attacks of Hereditary Angioedema with the Bradykinin B2 Receptor-Antagonist Icatibant

被引:1
|
作者
Farkas, H. [1 ]
Csuka, D. [1 ]
Zotter, Z. [1 ]
Varga, L. [1 ]
Boeroecz, Z. [1 ]
Temesszentandrasi, G. [1 ]
Karadi, I. [1 ]
机构
[1] Semmelweis Univ, Budapest, Hungary
关键词
D O I
10.1016/j.jaci.2010.12.926
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:AB233 / AB233
页数:1
相关论文
共 50 条
  • [1] Treatment of patients with acute attacks of hereditary angioedema due to C1-INH deficiency with the bradykinin B2 receptor-antagonist Icatibant
    Farkas, H.
    Varga, L.
    Szeplaki, G.
    Temesszentandrasi, G.
    Jakab, L.
    Fekete, B.
    Fust, G.
    Karadi, L.
    [J]. ALLERGY, 2008, 63 : 474 - 475
  • [2] Icatibant, a new bradykinin B2 receptor antagonist, for hereditary angioedema attacks
    Reshef, A.
    Liebovich, I.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) : S102 - S102
  • [3] Treatment for hereditary angioedema with the bradykinin (B2) receptor antagonist Icatibant (JE 049)
    Rosenkranz, B
    Meng, G
    Knolle, J
    Bork, K
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 : 166 - 167
  • [4] Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant)
    Bork, Konrad
    Frank, Jorge
    Grundt, Boris
    Schlattmann, Peter
    Nussberger, Juerg
    Kreuz, Wolfhart
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (06) : 1497 - 1503
  • [5] Treatment of acute edema attacks in Hereditary Angioedema with a bradykinin receptor-2 antagonist (Icatibant)
    Grundt, B.
    Bork, K.
    Frank, J.
    Schlattmann, P.
    Nussbergger, J.
    Rosenkranz, B.
    Dong, L.
    Knolle, J.
    Kreuz, W.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S278 - S278
  • [6] Treatment of repeated attacks of hereditary angioedema with bradykinin-B2-receptor antagonist icatibant
    Bork, K.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 161 - 162
  • [7] Successful long term treatment of 141 attacks in a patient with hereditary angioedema with the bradykinin B2 receptor antagonist icatibant
    Greve, J.
    Bas, M.
    Schuler, P.
    Schipper, J.
    Lang, S.
    Hoffmann, T.
    [J]. ALLERGY, 2009, 64 : 281 - 281
  • [8] The efficacy and safety of Icatibant, a selective bradykinin B2 receptor antagonist, for treating the symptoms of hereditary angioedema attacks
    Cicardi, M.
    [J]. ALLERGY, 2008, 63 : 474 - 474
  • [9] Treatment of idiopathic nonhistaminergic angioedema with bradykinin B2 receptor antagonist icatibant
    Del Corso, I.
    Puxeddu, I.
    Sardano, E.
    Geraci, S.
    Breggia, M.
    Rocchi, V.
    Migliorini, P.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 108 (06) : 460 - 461
  • [10] BRADYKININ RECEPTOR 2 ANTAGONIST (ICATIBANT) FOR HEREDITARY ANGIOEDEMA TYPE III ATTACKS
    Bouillet, Laurence
    Boccon-Gibod, Isabelle
    Ponard, Denise
    Drouet, Christian
    Cesbron, Jean Yves
    Dumestre-Perard, Chantal
    Monnier, Nicole
    Lunardi, Joel
    Massot, Christian
    Gompel, Anne
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : 448 - 448